Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses

Fig. 5

A Top left: The content of 22 immune cells in the high expression group and low expression group of MAPK10. Upper right: The content of 22 immune cells in the high expression group and low expression group of PPP2CB. Lower left: The content of 22 immune cells in the RAC3 high expression group and low expression group. Lower right: The content of 22 immune cells in the high-risk group and the low-risk group. B The image on the left shows the survival status of different expression levels of MAPK10, tumor stage, tumor purity, ESTIMATE score, immune score, matrix score, and immune response intensity (expression of eight immune-related genes). The image on the right displays the survival status of various expressions of PPP2CB, tumor stage, tumor purity, ESTIMATE mark, immune mark, matrix score, and the intensity of immune response (expression of eight immune-related genes). Subtypes of BLCA patients in TCGA

Back to article page